Found 7 matching trials
The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. PHASE3 Evaluate the Safety, Efficacy and Pharmacokinetics of Leuprolide Injectable...
Show More Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Learn More & Join Trial
Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg PHASE3 This is a safety extension of up to 12 months of additional treatment with ...
Show More Location
Urology Centers of Alabama
Learn More & Join Trial
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation PHASE2 Background:
* One way to treat certain cancers of the blood and immune sys...
Show More Location
Childrens National Medical Center
Learn More & Join Trial
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer PHASE2 Primary Objective:
1\. To evaluate the pathological complete response rate...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty PHASE3 The study will evaluate if Leuprolide Mesylate is safe and effective in the...
Show More Location
Arizona University
Learn More & Join Trial
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer PHASE3 The study will evaluate if Leuprolide Mesylate is safe and effective in the...
Show More Location
Urology Centers of Alabama
Learn More & Join Trial
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma PHASE3 The study will evaluate if Leuprolide Mesylate is safe and effective in the...
Show More Location
Urology Centers of Alabama
Learn More & Join Trial